News from

Health & Medicine

Reset All Filters
185 Results
AI tool, powered by nursing insight, cuts mortality

AI tool, powered by nursing insight, cuts mortality

An artificial intelligence tool that analyzes nurses’ notes to predict patient decline significantly reduces mortality risk and shortens hospital stays, according to a study published in Nature Medicine.

Meniscus injuries may soon be treated by customizable hydrogel

Meniscus injuries may soon be treated by customizable hydrogel

Researchers at the Perelman School of Medicine found a new 3D-printed customizable hydrogel performed well in preclinical trials with several different types of meniscal tears, offering a potential mend for common joint injuries.

Frank Otto

1 min. read

Advanced robotic imaging helps Rusty the therapy horse avoid surgery
A young rider on Rusty the horse.

Rusty, a 20-year-old Quarter Horse, helps riders with physical and cognitive disabilities build strength, confidence, and independence Thorncroft Equestrian Center. State-of-the-art robotic imaging at Penn’s New Bolton Center was key to Rusty’s diagnosis and treatment when he developed lameness in his leg.

(Image: Ryan Sansom)

Advanced robotic imaging helps Rusty the therapy horse avoid surgery

When Rusty, a 20-year-old therapy Quarter Horse, developed lameness in his right hind leg, his diagnosis required advanced imaging. Unlike traditional CT scanners, New Bolton Center’s robotic imaging was key to Rusty’s diagnosis and treatment when he developed lameness in his leg.

Sacha Adorno

2 min. read

Measles: An explainer
Judy O’Donnell.

Image: Courtesy of Penn Medicine

Measles: An explainer

Judy O’Donnell, the associate chief medical officer for Healthcare Epidemiology for the University of Pennsylvania Health System, and the chief of Infectious Diseases at Penn Presbyterian Medical Center, explains what people need to know about measles.

AI Month at Penn
Buildings on Penn's campus and a banner that reads 'Penn Engineering.'

Penn Engineering will host the second annual AI Month from April 1 to May 1.


 

nocred

AI Month at Penn

The School of Engineering and Applied Science is hosting 2025 AI Month at Penn, a monthlong series of events throughout April dedicated to the theme “AI and Human Well-Being.”

4 min. read

New technology is poised to bring gene therapy to common chronic diseases

New technology is poised to bring gene therapy to common chronic diseases

New research from Penn Medicine reveals a safe delivery system of DNA-loaded lipid nanoparticles directly to cells, which could transform treatment for common chronic diseases like heart disease, diabetes, and cancer.

From Penn Medicine News

2 min. read

Christina Roberto on food labeling and system-level changes for public health
Christina Roberto.

Christina Roberto is a Center for Health Incentives and Behavioral Economics affiliate and the Mitchell J. Blutt and Margo Krody Blutt Presidential Associate Professor of Health Policy in the Perelman School of Medicine.

(Image: Courtesy of CHIBE)

Christina Roberto on food labeling and system-level changes for public health

The Center for Health Incentives and Behavioral Economics affiliate studies labeling systems to improve the choices people make with food, and argues that if health care professionals are serious about preventing nutrition-related chronic diseases, then system-level changes are necessary.

From the Center for Health Incentives and Behavioral Economics

2 min. read

2025 CAREER Award recipient: Jina Ko

2025 CAREER Award recipient: Jina Ko

Ko, a professor in bioengineering in Penn Engineering and in Pathology and Laboratory Medicine in the Perelman School of Medicine, is awarded the 2025 National Science Foundation (NSF) CAREER Award for her expertise across bioengineering, molecular biology, and chemistry in developing transformative technologies for molecular diagnostics of diseases, especially with respect to how brain-related conditions are diagnosed and treated.

Immunotherapy may boost KRAS-targeted therapy in pancreatic cancer

Immunotherapy may boost KRAS-targeted therapy in pancreatic cancer

A preclinical study from the Perelman School of Medicine and Penn Medicine’s Abramson Cancer Center that combines RAS inhibition and immunotherapy shows promise for future clinical trials in pancreatic cancer treatment strategies.

Meagan Raeke

1 min. read